Test Price
2,800 AED✅ Home Collection Available
COL11A1 Gene Fibrochondrogenesis Type 1 Genetic Test in UAE | 2800 AED | DHA Licensed
✓ Precision Guarantee:
99.9% Diagnostic Sensitivity via ISO 15189 & ISO 9001:2015 Accredited Processing.
🚚 Premium Home Collection:
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM Daily).
📞 Clinical Guidance:
Telephonic Post-Test Clinical Guidance for result interpretation by certified genetic counselors.
💳 Insurance Verification:
Direct Billing Verification via WhatsApp +971 54 548 8731 (pre-approval support).
Executive Summary & Core Metrics
The COL11A1 Gene Fibrochondrogenesis Type 1 Genetic Test utilizes Next-Generation Sequencing (NGS) to analyze the complete coding region of the COL11A1 gene for pathogenic variants associated with this severe autosomal dominant skeletal dysplasia. This test enables early diagnosis, comprehensive family risk assessment, and personalized multidisciplinary management planning. Processing is conducted at DNA Labs UAE, a DHA-licensed facility (License No. 1143) in Dubai Healthcare City, under strict ISO 15189 and ISO 9001:2015 quality frameworks with 99.9% diagnostic sensitivity and full CNV analysis integration.
99.9%
Diagnostic Sensitivity
2,800
AED Price
3–4
Weeks TAT
Blood
Sample Type
Test Overview & Methodology
The COL11A1 Gene Fibrochondrogenesis Type 1 NGS test analyzes the entire coding region of the COL11A1 gene for pathogenic variants associated with this severe autosomal dominant skeletal dysplasia. It aids early diagnosis, family risk assessment, and personalized management. The test employs next-generation sequencing with full gene coverage and CNV analysis, providing superior resolution compared to conventional Sanger sequencing methods.
| Feature | Our Test (NGS Panel) | Standard Sanger Sequencing |
|---|---|---|
| Diagnostic Sensitivity | 99.9% | ~95% |
| Methodology | Next-Generation Sequencing (NGS) with full gene coverage & CNV analysis | Single-gene Sanger |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Sample Type | Blood, Extracted DNA, or One-drop Blood on FTA Card | Blood only |
| Price | 2,800 AED | 3,500+ AED (est.) |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics specialist, I emphasize that a positive COL11A1 variant must be correlated with detailed clinical findings and imaging to establish a definitive diagnosis of fibrochondrogenesis. Genetic results should be interpreted by a multidisciplinary team including a clinical geneticist, orthopedic surgeon, and genetic counselor to guide prognosis and family planning. Never rely solely on genetic data; physical examination and radiology are paramount."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic testing does not replace routine medical care or existing treatment plans. Always consult your specialist before making any changes to your medication regimen.
Exclusion Criteria & Clinical Red Flags
- Patients with active infections or febrile illness should postpone sample collection until fully recovered.
- Individuals unable to consent (mentally incapacitated) require legal guardian authorization as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Immediate ER evaluation required for suspected complications like acute skeletal pain, respiratory distress, or joint dislocation.
- Prenatal testing must follow DHA guidelines and include mandatory genetic counseling prior to sample collection.
Patient FAQ & Clinical Guidance
1. What is the COL11A1 fibrochondrogenesis test and why is it needed in the UAE?
This test identifies pathogenic mutations in the COL11A1 gene, causing fibrochondrogenesis type 1, a severe inherited skeletal dysplasia with distinctive facial features, bone fragility, and skin changes. Early genetic diagnosis enables informed reproductive decisions and targeted multidisciplinary care in Dubai, Abu Dhabi, and all Emirates.
2. How accurate and reliable is this genetic test?
With 99.9% diagnostic sensitivity and ISO 15189 and ISO 9001:2015 accredited laboratory processing, our test meets the highest international standards for variant interpretation and clinical reporting. All results are reviewed by board-certified geneticists before final release.
3. Is home sample collection available and covered by insurance?
Yes, our VIP mobile phlebotomy service offers hospital-grade home collection from 8 AM to 11 PM daily across the UAE, with direct billing verification via WhatsApp at +971 54 548 8731 to confirm your coverage before the draw. The service uses temperature-controlled cold-chain logistics to maintain specimen integrity.
4. What is the turnaround time for results?
The standard turnaround time is 3–4 weeks from sample receipt at the laboratory. This timeline accounts for comprehensive NGS sequencing, bioinformatic analysis, variant interpretation, and clinical correlation before report generation.
5. How do I prepare for the sample collection?
No special preparation is required for this blood test. You may eat and drink normally before the collection. However, inform the phlebotomist if you are taking any anticoagulant medications. A valid Emirates ID or passport is required for identity verification at the time of collection.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License No. 1143 and strictly adheres to the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, stored securely, and accessible only to authorized medical personnel. Patient consent is obtained in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability. Data is never shared with third parties without explicit written consent from the patient or their legal guardian.
Clinical & Logistical Metadata
| Test Name | COL11A1 Gene Fibrochondrogenesis Type 1 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral), Extracted DNA, or Dried Blood Spot (FTA Card) |
| Methodology Used | Next-Generation Sequencing (NGS) with Full Gene Coverage & CNV Analysis |
| ICD-10-CM Code | Q77.3 (Chondrodysplasia punctata), Q78.8 (Other specified osteochondrodysplasias) |
| LOINC Code | 82161-8 (COL11A1 gene mutation analysis) |
| DHA Facility License & Laboratory Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians